Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Exchange Rate Effect (2016 - 2025)

Lineage Cell Therapeutics' Exchange Rate Effect history spans 16 years, with the latest figure at $180000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 620.0% year-over-year to $180000.0; the TTM value through Dec 2025 reached $396000.0, up 516.84%, while the annual FY2025 figure was $396000.0, 516.84% up from the prior year.
  • Exchange Rate Effect reached $180000.0 in Q4 2025 per LCTX's latest filing, up from -$4000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $293000.0 in Q2 2025 to a low of -$634000.0 in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$42100.0, with a median of -$56000.0 recorded in 2022.
  • Peak YoY movement for Exchange Rate Effect: crashed 7144.44% in 2022, then skyrocketed 620.0% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at $14000.0 in 2021, then crashed by 657.14% to -$78000.0 in 2022, then skyrocketed by 461.54% to $282000.0 in 2023, then tumbled by 91.13% to $25000.0 in 2024, then surged by 620.0% to $180000.0 in 2025.
  • Per Business Quant, the three most recent readings for LCTX's Exchange Rate Effect are $180000.0 (Q4 2025), -$4000.0 (Q3 2025), and $293000.0 (Q2 2025).